Menu

Vitamin A for edible oil fortification

Vitamin A deficiency has particularly adverse consequences for women of reproductive age and children. It can lead to blindness, impaired growth and increased severity of infectious diseases.

MedAccess will provide a volume guarantee to dsm-firmenich to provide stable pricing and sustainable supply of vitamin A for edible oil millers, ensuring greater access to fortified cooking oil.

All agreements
Current agreement

Our
partners

dsm-firmenich logo

The challenge

Public health

Vitamin A deficiency affects approximately 500 million people globally, mainly in Africa and Asia. It is particularly prevalent in low- and middle-income countries (LMICs) due to food insecurity and limited dietary diversity.

A deficiency in vitamin A has particularly adverse consequences for women of reproductive age and children, leading to blindness, impaired growth, and increased severity of infectious diseases.

In children, vitamin A deficiency significantly increases the risk of illness and death from common infections such as diarrhoea and measles. It is also the leading preventable cause of blindness. In women of reproductive age, vitamin A deficiency increases the risk of maternal night blindness, infection, and other adverse outcomes during pregnancy and lactation.

Market situation

The vitamin A market frequently sees severe price volatility and supply insecurity due to market disruptions.

Although fortification with vitamin A is mandatory in many countries, edible oil millers often face significant challenges to fortify their products when the price of vitamin A increases or supplies become scarce. This makes it difficult for millers to plan ahead, procure consistently, and fortify oil in adequate volumes.

This first-of-its-kind partnership supports predictable vitamin A prices in an important market where fortified food is a big contributor to ensuring people benefit from vitamin A.

The product

Vitamin A is essential for the functioning of the immune system and healthy growth of children. People can become deficient in the vitamin due to a limited diet.

Food fortification involves adding safe levels of micronutrients such as vitamin A to commonly consumed foods such as cooking oil, to increase their nutrient content. Edible oil millers blend vitamin A into the oil during production. Consumers benefit from the fortified oil in their daily cooking.

The fortification of edible oil with vitamin A is mandated in several LMICs. Supporting edible oil millers to access vitamin A at affordable, predictable prices stable prices can support compliance efforts.

The partnership

MedAccess has partnered with dsm-firmenich to provide stable pricing and sustainable supply of vitamin A, ensuring a more affordable and transparent price for edible oil millers in LMICs. This initiative will significantly increase the amount of fortified oil available, therefore improving public health outcomes.

dsm-firmenich will not exceed ceiling prices of $59 per kg (ex-works) for vitamin A and $43.30 per kg (ex-works) for a vitamin A and D3 blend when sold to edible oil millers for fortification in low- and middle-income countries (LMICs).

To enable dsm-firmenich to offer these ceiling prices, MedAccess will provide a volume guarantee, covering any shortfall in agreed sales.

Impact projections

Our guarantee will contribute to stabilised prices and sustained supply of vitamin A, to support the continued fortification of edible oil.

By stabilising prices, this guarantee will address historical price volatility, improving visibility and supply security for edible oil millers, and support longer-term planning and forecasting to ensure adequate fortification.

Using evidence from supplementation trials to approximate the potential benefits of fortification, we project that improved access to oil fortified with vitamin A can contribute to:

  • 1.21 million cases of vitamin A deficiency addressed in children under five
  • 1.14 million cases of anaemia addressed in children under five.

How we calculate the impact of this agreement

Lives changed

Evidence for the benefits of food fortification is limited due to the complexities of controlled nutrition monitoring. Vitamin A supplementation clinical trials were used as a proxy to estimate the benefit of daily, continued consumption of fortified oil. Estimates for cases of vitamin A deficiency addressed were based on a meta-analysis by Imdad et al.

Money saved

Impact is based on comparing the negotiated price to the historical median market price.

Markets shaped

We work with partners, including donors and procurers to track changes in health markets where our investments are supporting access to products. We monitor for changes to policy, procurement practices and supplier movement, all of which affect markets and contribute to the long-term sustainability of impact.

Sustainable Development Goals (SDGs)

SDG 3

SDG 3

Ensure healthy lives and promote well-being for all at all ages
SDG 3 targets:
SDG 10

SDG 10

Reduce inequality within and among countries
SDG 10 target:
SDG 17

SDG 17

Strengthen the means of implementation and revitalize the Global Partnership for Sustainable Development
SDG 17 targets:
  • SDG 3

    SDG 3

    Ensure healthy lives and promote well-being for all at all ages
    SDG 3 targets:
  • SDG 10

    SDG 10

    Reduce inequality within and among countries
    SDG 10 target:
  • SDG 17

    SDG 17

    Strengthen the means of implementation and revitalize the Global Partnership for Sustainable Development
    SDG 17 targets:

SDG 3

3.3

By 2030, end the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases and combat hepatitis, water-borne diseases and other communicable diseases


3.8

Achieve universal health coverage, including financial risk protection, access to quality essential health-care services and access to safe, effective, quality and affordable essential medicines and vaccines for all


3.b

Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all

SDG 10

10a

Implement the principle of special and differential treatment for developing countries, in particular least developed countries, in accordance with World Trade Organization agreements

SDG 17

17.6

Enhance North-South, South-South and triangular regional and international cooperation on and access to science, technology and innovation and enhance knowledge sharing on mutually agreed terms, including through improved coordination among existing mechanisms, in particular at the United Nations level, and through a global technology facilitation mechanism


17.7

Promote the development, transfer, dissemination and diffusion of environmentally sound technologies to developing countries on favourable terms, including on concessional and preferential terms, as mutually agreed


17.10

Promote a universal, rules-based, open, non-discriminatory and equitable multilateral trading system under the World Trade Organization, including through the conclusion of negotiations under its Doha Development Agenda


17.17

Encourage and promote effective public, public-private and civil society partnerships, building on the experience and resourcing strategies of partnerships

Key contacts

If you would like more information about this agreement, please reach out to our key contacts.

Subscribe to our newsletter

Receive regular updates about how our innovative finance work is making healthcare products more affordable and accessible.

Close